Water
Water is used across multiple medical products as a diluent, irrigant, and vehicle for drug delivery, and is also found in ophthalmic eye wash products for cleansing and soothing irritated eyes.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 36 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Water: Patient Information Guide
A plain-language walkthrough of Water — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Water is the active or vehicle ingredient in several different FDA-approved products, each with its own distinct approved use.
- Sterile Water for Injection: used intravenously as a solvent or diluent for other drugs, or as a source of water for parenteral fluid replenishment after appropriate additives are added
- Sterile Water for Injection (diluent use): used to dilute or dissolve drugs for intravenous, intramuscular, or subcutaneous injection, per each drug manufacturer's instructions
- Sterile Water for Irrigation: used as an irrigating fluid or pharmaceutical aid, and to help prepare non-intravenously administered nutrient mixtures
- Insulin Diluting Medium for Garzulys: used with Garzulys (a rapid-acting insulin aspart analog) to improve glycemic control in adults and children with diabetes mellitus
- INSULIN DILUTING MEDIUM FOR Kirsty: used with Kirsty (a rapid-acting insulin aspart analog) to improve glycemic control in adults and children with diabetes mellitus
- Crane Safety Eye Wash, Dynamic Eyewash with Eyecup, Easy Care First Aid Eyewash: ophthalmic use to cleanse the eye, remove loose foreign material, and relieve irritation or burning
- Eyes Alive Eye Wash: ophthalmic use to flush the eye and relieve irritation, discomfort, burning, stinging, smarting, or itching, and to remove loose foreign material, air pollutants (such as smog or pollen), or chlorinated water
⚙️How it works▾
When water is used as part of insulin diluting products, it serves as the carrier for the active insulin. The insulin itself — an analog called insulin aspart — regulates blood sugar by prompting muscle and fat cells to take up glucose from the blood, reducing the liver's output of glucose, and supporting the body's ability to build and store proteins and fats. As a sterile diluent or irrigant, water works physically: it dissolves or dilutes medications for safe delivery, or mechanically flushes surfaces such as the eye or a body cavity.
💊How it's taken▾
How and when water-based products are used depends entirely on the specific product.
- Sterile Water for Injection: given intravenously only after being properly mixed with drug additives — never administered as plain water by IV
- Sterile Water for Irrigation: applied to body surfaces or cavities as directed; volume and rate depend on the procedure; not for IV use
- Insulin diluting mediums (Garzulys, Kirsty): the diluted insulin is injected subcutaneously within 5–10 minutes before a meal, rotating sites; dose is set by your prescriber
- Eye wash products: applied directly to the eye as needed; follow individual product label directions
🤒Side effects — in detail▾
Side effects depend on the specific product. With insulin aspart products that use water as a vehicle, the most common reactions include:
- Low blood sugar (hypoglycemia) — the most frequent concern
- Injection site reactions: redness, swelling, or itching
- Skin changes at injection sites: lipoatrophy (skin depression) or lipohypertrophy (skin thickening)
- Rash or generalized itching
- Swelling (edema), particularly with intensified insulin therapy
- Weight gain
- Headache and nausea
Severe low blood sugar, serious allergic reactions (including anaphylaxis), and dangerously low potassium (hypokalemia) are rare but life-threatening and require immediate medical attention.
⚠️Warnings & precautions▾
- Hypoglycemia (low blood sugar) is the most serious risk with insulin products. It can be life-threatening, cause seizures or unconsciousness, and impair your ability to drive or operate machinery. Risk increases with changes in dose, meals, activity, or other medications.
- Sterile Water for Injection must never be given plain by IV — it is hypotonic (lacks salts) and can cause hemolysis (destruction of red blood cells). It must be made approximately isotonic by adding the proper solute before intravenous use.
- Fluid and electrolyte overload is possible with large-volume intravenous fluid administration, potentially leading to pulmonary edema (fluid in the lungs) or dilution of blood salts.
- Aluminum toxicity: some parenteral water preparations contain aluminum, which can accumulate to toxic levels in patients with impaired kidney function — especially premature newborns — and may cause nerve and bone damage.
- Hypokalemia (low potassium): insulin can shift potassium into cells, potentially causing dangerous drops in blood potassium levels, leading to abnormal heart rhythms or respiratory problems.
- Heart failure risk: using insulin together with thiazolidinedione (TZD) diabetes pills can cause fluid retention and worsen or trigger heart failure.
🔀What it interacts with▾
When water is part of an insulin aspart product, several drugs and substances can affect how well blood sugar is controlled:
- Drugs that increase low-blood-sugar risk: other antidiabetic medications, ACE inhibitors, angiotensin II receptor blockers, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, pramlintide, salicylates, octreotide, and sulfonamide antibiotics
- Drugs that raise blood sugar and reduce insulin's effect: corticosteroids, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones
- Drugs with unpredictable effects on blood sugar: alcohol, beta-blockers, clonidine, lithium salts, and pentamidine (which may first cause low then high blood sugar)
- Drugs that hide low-blood-sugar warning signs: beta-blockers, clonidine, guanethidine, and reserpine can mask symptoms like a racing heart, making it harder to notice a blood sugar drop
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Allergy: Garzulys is contraindicated in anyone allergic to insulin aspart or any of its ingredients
- Active hypoglycemia: Garzulys must not be used during an episode of low blood sugar
- Kidney impairment: patients with kidney disease may be at higher risk of low blood sugar and may need more frequent dose adjustments and blood sugar monitoring
- Liver impairment: patients with liver disease may also need closer monitoring and possible dose adjustments
- Pregnancy: poorly controlled diabetes in pregnancy increases risks for both mother and baby; insulin aspart products have been studied in the second trimester and have not been linked to major birth defects, but discuss all insulin use with your doctor
- Breastfeeding: limited data exist on insulin aspart in breast milk; discuss the risks and benefits with your doctor
- Children: Garzulys is approved for children aged 6 and older with diabetes mellitus
- Older adults: use with caution; hypoglycemia risk may be higher and signs may be less obvious
- Premature newborns: particularly vulnerable to aluminum toxicity from parenteral water preparations due to immature kidneys
🚑If you take too much▾
Overdose with treprostinil injection products (which use sterile diluent/water as a vehicle) can cause flushing, headache, low blood pressure, nausea, vomiting, and diarrhea — most cases resolve when the infusion is reduced or stopped. In rare serious cases, overdose has caused severe low blood pressure and, in one pediatric case involving a large accidental dose given through a central venous catheter, seizure-like activity and loss of consciousness — that patient recovered. If you suspect an overdose, seek emergency medical help immediately.
📡Pharmacodynamics — effects in the body▾
When insulin aspart (delivered via water-based injection products) is given subcutaneously, its peak blood-sugar-lowering effect occurs within 1 to 3 hours after injection, and the effect lasts about 3 to 5 hours. The exact timing can vary from person to person and even in the same person on different days, depending on injection site, physical activity, and other factors. When given intravenously, insulin aspart produces a blood sugar profile similar to regular human insulin.
🔬Pharmacokinetics — how your body processes it▾
For treprostinil injection products that use sterile diluent (water) as a vehicle: treprostinil is absorbed rapidly and almost completely after subcutaneous infusion, reaching steady-state levels in about 10 hours. It is heavily metabolized by the liver (primarily by the CYP2C8 enzyme) and eliminated mainly in urine. Its terminal half-life is approximately 4 hours. Patients with liver impairment clear the drug much more slowly — up to 80% less clearance — so they need lower starting doses and careful monitoring.
📦How to store it▾
Dispense in the original sealed carton with the enclosed Instructions for Use. Store unused NOVOLOG in a refrigerator between 2°C to 8°C (36°F to 46°F). Do not freeze NOVOLOG and do not use NOVOLOG if it has been frozen.
📄 Written from Water’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Water — the kind of thing our pharmacy team would talk through with you at the counter.
Why is 'water' listed as the active ingredient on my medicine? ▾
Is Sterile Water for Injection the same as the eye wash or the irrigation product? ▾
My insulin vial says 'Insulin Diluting Medium' — what does that mean for me? ▾
What are the most important warning signs to watch for with insulin products that contain water as a vehicle? ▾
Can I use these eye wash products every day? ▾
Are there any medicines I should tell my doctor about before using an insulin product that contains this diluting medium? ▾
Is Water available over the counter? ▾
When was Water first available? ▾
Who makes Water? ▾
💬 Answers drafted from Water’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Water comes
Water is available in 8 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Injection
How this form is used
- Bacteriostatic Water and Sterile Water injection products: used only to dilute or dissolve drugs for intravenous, intramuscular, or subcutaneous injection per the drug manufacturer's instructions
- Insulin Diluting Medium for Garzulys: used to dilute Garzulys (insulin aspart) to improve glycemic control in adults and children with diabetes mellitus
- INSULIN DILUTING MEDIUM FOR Kirsty: used to dilute Kirsty (insulin aspart) to improve glycemic control in adults and children with diabetes mellitus
- Bacteriostatic Water and Sterile Water: use only as a diluent per the instructions of the drug being reconstituted — never inject plain water intravenously without additives
- Insulin Diluting Medium for Garzulys: used with Garzulys subcutaneous injection, given within 5–10 minutes before a meal; rotate injection sites to reduce skin changes
- INSULIN DILUTING MEDIUM FOR Kirsty: used with Kirsty subcutaneous injection, given within 5–10 minutes before a meal; rotate injection sites within the same region
- Follow your prescriber's instructions for dosing and administration of the specific insulin product
Show 7 more strengths Show fewer strengths
Eye drops
How this form is used
- Crane Safety Eye Wash: cleanses the eye to remove loose foreign material and relieve irritation and burning
- Dynamic Eyewash with Eyecup and Easy Care First Aid Eyewash: cleanse the eye to help relieve irritation or burning by removing loose foreign material
- Eyes Alive Eye Wash: flushes the eye to relieve irritation, discomfort, burning, stinging, smarting, or itching, and to remove loose foreign material, air pollutants, or chlorinated water
- Apply directly to the eye as needed to flush and cleanse
- Follow the directions on the individual product label for proper use
Show 8 more strengths Show fewer strengths
Other oral form
How this form is used
- Sterile Water for Irrigation: used as an irrigating fluid or pharmaceutical aid
- Sterile Water for Irrigation: may be used as an adjunct in preparing non-intravenously administered nutrient mixtures
- Sterile Water for Irrigation: for irrigation use only — not for intravenous injection or infusion
- Sterile Water for Irrigation: volume and rate of use depend on the procedure; follow physician's directions
Oral solution
Show 1 more strength Show fewer strengths
Topical solution
How this form is used
- Eye Wash (topical): cleanses the eye to help relieve irritation or burning by removing loose foreign material
- Eye Wash (topical): apply to the eye as directed on the product label to flush and cleanse
Sublingual tablet
Topical spray
Vaginal insert
📊 Water across the U.S. market
How Water appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Water is used
A general measure of how commonly Water is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Water is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Water prescribed? Of the 1,594 medications we measure, Water ranks #390 by Medicaid prescriptions — more than 76% of them.
Utilization by Water product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
water 1000 MG/ML Irrigation Solution Most dispensed
Summed across the 10 of 40 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 150985
water 991 MG/ML Ophthalmic Irrigation Solution
Summed across the 2 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1053429
Other Water products — combination packs and listings not yet matched to a specific clinical product (kept visible so every prescription is accounted for)
Summed across the 26 of 164 listed NDC products with Medicaid activity.
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Water, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 38 of 234 listed Water NDCs with Medicaid activity.
🔍 Compare Water products
A representative set of FDA-listed product records for Water — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye drops | ||||
| 0.98 mL/mL | Ophthalmic | Acme United Corporation | OTC MONOGRAPH FINAL | View NDC → |
| 929 g/946 mL | Ophthalmic | Akorn | NDA | View NDC → |
| 99.05 mL/100 mL | Ophthalmic | Bausch & Lomb Incorporated × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 98.3 mL/100 mL | Ophthalmic | Bel-Art | OTC MONOGRAPH FINAL | View NDC → |
| 0.98 mL/mL | Ophthalmic | Cintas Corporation | OTC MONOGRAPH FINAL | View NDC → |
| 991 mg/mL | Ophthalmic | CMC Group Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 991 mg/mL | Ophthalmic | CMC Group Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 0.983 mg/mL | Ophthalmic | Crane Safety LLC × 2 listings | NDA | View NDC → |
| 99.05 mL/100 mL | Ophthalmic | CVS Pharmacy | OTC MONOGRAPH FINAL | View NDC → |
| 980 mg/mL | Ophthalmic | Division 5 Labs, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 929 g/946 mL | Ophthalmic | Dynamic Safety International × 2 listings | NDA | View NDC → |
| 14.85 mL/15 mL | Ophthalmic | Eyes-Plus LLC | OTC MONOGRAPH DRUG | View NDC → |
| 14.85 mL/15 mL | Ophthalmic | Eyes-Plus LLC × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 99.05 mL/100 mL | Ophthalmic | Genuine Drugs × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 929 g/946 mL | Ophthalmic | Henry Schein, Inc. | NDA | View NDC → |
| 70 mL/100 mL | Ophthalmic | Honeywell Safety Products USA, Inc | OTC MONOGRAPH NOT FINAL | View NDC → |
| 70 mL/100 mL | Ophthalmic | Honeywell Safety Products USA, Inc | OTC MONOGRAPH DRUG | View NDC → |
| 92.2 L/100 L | Ophthalmic | Honeywell Safety Products USA, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 92.2 L/100 L | Ophthalmic | Honeywell Safety Products USA, Inc | OTC MONOGRAPH DRUG | View NDC → |
| 95.1 mL/100 mL | Ophthalmic | Innovative Safety Supply Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 929 g/946 mL | Ophthalmic | Mwi | NDA | View NDC → |
| 929 g/946 mL | Ophthalmic | Niagara Pharmaceuticals Inc. × 9 listings | NDA | View NDC → |
| 0.988 mL/mL | Ophthalmic | Optics Laboratory Inc. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.988 mL/mL | Ophthalmic | Optics Laboratory Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 99.05 mL/100 mL | Ophthalmic | Rite Aid Corporation | OTC MONOGRAPH DRUG | View NDC → |
| 99.05 mL/100 mL | Ophthalmic | Rite Aid Corporation | OTC MONOGRAPH FINAL | View NDC → |
| 98.4 mL/100 mL | Ophthalmic | Sato Pharmaceutical Co., Ltd. | OTC MONOGRAPH FINAL | View NDC → |
| 98.4 mL/100 mL | Ophthalmic | Sato Pharmaceutical Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| 💊Injection | ||||
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | A-S Medication Solutions | NDA | View NDC → |
| 1 mL/mL | Intramuscular; Intravenous; Subcutaneous | A-S Medication Solutions | NDA | View NDC → |
| 0.025 g/mL | Subcutaneous | ALK-Abello, Inc. × 2 listings | BLA | View NDC → |
| 0.025 g/mL | Percutaneous | ALK-Abello, Inc. × 2 listings | BLA | View NDC → |
| 0.05 g/mL | Subcutaneous | ALK-Abello, Inc. | BLA | View NDC → |
| 1000 [PNU]/mL | Intradermal | ALK-Abello, Inc. | BLA | View NDC → |
| 20000 [PNU]/mL | Subcutaneous | ALK-Abello, Inc. | BLA | View NDC → |
| 40000 [PNU]/mL | Subcutaneous | ALK-Abello, Inc. | BLA | View NDC → |
| 1 mL/mL | Intravenous | American Regent, Inc. × 2 listings | UNAPPROVED DRUG OTHER | View NDC → |
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | Asclemed USA, Inc. | NDA | View NDC → |
| 0.7 mL/mL | — | Aspen Notre Dame De Bondeville | DRUG FOR FURTHER PROCESSING | View NDC → |
| 1 mL/mL | Intravenous | B. Braun Medical Inc. × 3 listings | NDA | View NDC → |
| 0.65 mL/0.65 mL | Subcutaneous | Bavarian Nordic A/S | BLA | View NDC → |
| 100 mL/100 mL | Intravenous | Baxter Healthcare Company × 6 listings | NDA | View NDC → |
| 1 mL/mL | Irrigation | Becton Dickinson and Company | ANDA | View NDC → |
| 1000 mL/1000 mL | Intravenous | Becton Dickinson and Company × 2 listings | ANDA | View NDC → |
| 1 mL/mL | Intravenous, Subcutaneous | Biocon Biologics Inc. × 2 listings | BLA | View NDC → |
| 1 mL/mL | Intramuscular; Intravenous; Subcutaneous | Cardinal Health | NDA | View NDC → |
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | Cardinal Health 107, LLC × 2 listings | ANDA | View NDC → |
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | Cardinal Health 107, LLC × 2 listings | NDA | View NDC → |
| 1 mL/mL | Intramuscular; Intravenous; Subcutaneous | Cardinal Health 107, LLC | NDA | View NDC → |
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | Civica, Inc. | ANDA | View NDC → |
| 1 mL/mL | Intramuscular; Intravenous; Subcutaneous | Civica, Inc. | ANDA | View NDC → |
| 1 mL/mL | Intravenous | Dr.Reddy's Laboratories Inc., × 2 listings | ANDA | View NDC → |
| 1 mL/mL | Irrigation | Fresenius Kabi USA, LLC × 3 listings | ANDA | View NDC → |
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | Fresenius Kabi USA, LLC × 2 listings | ANDA | View NDC → |
| 1000 mL/1000 mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 1 mL/mL | — | Fujian Genohope Biotech Ltd. × 2 listings | BULK INGREDIENT | View NDC → |
| 1 mg/mL | Subcutaneous | Genentech, Inc. | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE | Find on DailyMed ↗ |
| 1 mL/mL | Intramuscular; Intravenous; Subcutaneous | General Injectables & Vaccine, Inc | NDA | View NDC → |
| 1 mL/mL | Intramuscular; Intravenous; Subcutaneous | General Injectables & Vaccines, Inc × 2 listings | NDA | View NDC → |
| 1 mL/mL | Intramuscular; Intravenous; Subcutaneous | General Injectables and Vaccines, Inc. × 2 listings | NDA | View NDC → |
| 1 mL/mL | Intravenous | GlaxoSmithKline LLC × 2 listings | NDA | View NDC → |
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | Henry Schein, Inc. × 3 listings | NDA | View NDC → |
| 1 mL/mL | Intramuscular; Intravenous; Subcutaneous | Henry Schein, Inc. × 6 listings | NDA | View NDC → |
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | Henry Schein, Inc. | ANDA | View NDC → |
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 1 mL/mL | Intramuscular; Intravenous; Subcutaneous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | Hospira, Inc. × 2 listings | NDA | View NDC → |
| 1 mL/mL | — | Hospira, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 1 mL/mL | Intramuscular; Intravenous; Subcutaneous | Hospira, Inc. × 2 listings | NDA | View NDC → |
| 1 mL/mL | Intravenous | ICU Medical Inc. × 3 listings | NDA | View NDC → |
| 1000 mL/1000 mL | Intravenous | ICU Medical Inc. × 4 listings | NDA | View NDC → |
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | Medical Purchasing Solutions, LLC × 2 listings | NDA | View NDC → |
| 1 mL/mL | Intramuscular; Intravenous; Subcutaneous | Medical Purchasing Solutions, LLC × 3 listings | NDA | View NDC → |
| 1 mL/mL | Intravenous, Subcutaneous | Meitheal Pharmaceuticals Inc. | BLA | View NDC → |
| 10 mL/10 mL | Intramuscular; Intravenous; Subcutaneous | Nexus Pharmaceuticals Inc | ANDA | View NDC → |
| 20 mL/20 mL | Intramuscular; Intravenous; Subcutaneous | Nexus Pharmaceuticals Inc | ANDA | View NDC → |
| 1 mL/mL | Intravenous, Subcutaneous | Novo Nordisk | BLA | View NDC → |
| 1 mL/mL | Intravenous; Subcutaneous | Novo Nordisk × 2 listings | BLA | View NDC → |
| 1 mL/mL | — | Patheon Manufacturing Services LLC × 3 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| 1 mL/mL | Intravenous | ProPharma Distribution | NDA | View NDC → |
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | ProPharma Distribution | NDA | View NDC → |
| 1 mL/mL | Intramuscular, Intravenous, Subcutaneous | Remedyrepack Inc. | NDA | View NDC → |
| 1 mL/mL | Intravenous, Subcutaneous | Sandoz Inc | ANDA | View NDC → |
| 1 mL/mL | Intravenous; Subcutaneous | Sandoz Inc | ANDA | View NDC → |
| 1 mL/mL | — | Siegfried Hameln GmbH × 19 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| 1 mL/mL | Intravenous | United Therapeutics Corporation × 4 listings | NDA | View NDC → |
| 💊Oral solution | ||||
| 0.0029 g/100 g | Oral | BIOHERB Co., Ltd. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.0029 g/100 g | Oral | Dmbio.co.,ltd. × 2 listings | UNAPPROVED DRUG OTHER | View NDC → |
| 929 g/946 mL | — | Isomedix Operations Inc. × 3 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| 99.9974 g/100 L | Oral | Jesus Glory Bio Co.,Ltd. | UNAPPROVED DRUG OTHER | View NDC → |
| 99.9974 g/100 mL | Oral | Jesus Glory Bio Co.,Ltd. | UNAPPROVED DRUG OTHER | View NDC → |
| 5 mL/5 mL | — | Klosterfrau Berlin GmbH | DRUG FOR FURTHER PROCESSING | View NDC → |
| 1 mL/mL | — | Laboratorios Grifols Sa × 2 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| 5 [hp_X]/0.095 mL | Oral | Nelson Bach USA Limited × 2 listings | UNAPPROVED HOMEOPATHIC | View NDC → |
| 💊Other oral form | ||||
| 1 mL/mL | Irrigation | B. Braun Medical Inc. × 2 listings | NDA | View NDC → |
| 100 mL/100 mL | Irrigation | Baxter Healthcare Corporation × 6 listings | NDA | View NDC → |
| 1 mL/mL | Irrigation | ICU Medical Inc. × 7 listings | NDA | View NDC → |
| 💊Sublingual tablet | ||||
| 30 [hp_X]/mL | Sublingual | DNA Labs, Inc. × 2 listings | UNAPPROVED HOMEOPATHIC | View NDC → |
| 💊Topical solution | ||||
| 991 mg/mL | Topical | Hubei Changjian Medical Products Co., Ltd. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 991 mg/mL | Topical | Jiangxi Zhenmei Biological Technology Co.,Ltd | OTC MONOGRAPH DRUG | View NDC → |
| 991 mg/mL | Topical | Jiangxi Zhenmei Biological Technology Co.,Ltd | OTC MONOGRAPH FINAL | View NDC → |
| 99.1 mL/100 mL | Topical | M-star (Hubei) Health&Care Products Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| 💊Vaginal insert | ||||
| 6.7 g/200 mL | Rectal, Vaginal | SB Innovations LLC | UNAPPROVED DRUG OTHER | View NDC → |
Showing 200 of 219 products — FDA National Drug Code Directory. See every product, package size and price: browse all 219 Water NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Water — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Water in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Water went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 11295 3 dose forms · 13 strengths
-
Dose form (SCDF) Inhalation Solution RxCUI 2108561No current FDA listingClinical drug / strength (SCD) 1000 MG/MLRxCUI 204918 -
Dose form (SCDF) Irrigation Solution RxCUI 379002In current FDA listingsClinical drug / strength (SCD) 1000 MG/MLRxCUI 150985 -
Dose form (SCDF) Ophthalmic Irrigation Solution RxCUI 1043588In current FDA listings
Look up RxCUI 11295 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Water is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 36 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Biocon Biologics Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.